Takeda Pharmaceutical: New Drug Application Approval in Japan for Copaxone® Subcutaneous Injection 20 mg Syringe, a Drug for the Treatment of Multiple Sclerosis

Accessed on 29 Sep 2015 from http://www.businesswire.com/news/home/20150928005506/en/Takeda-Pharmaceutical-Drug-Application-Approval-Japan-Copaxone®#.Vgr0Ps4buXs.